- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01271036
Safety Study of a Sensitive Sensual Touch and Personal Lubricant
January 30, 2014 updated by: Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.
A Single-Center, Medically Supervised, Safety Evaluation Study of a Sensitive Sensual Touch and Personal Lubricant Product in Couples
This is a one week study designed to test the safety of a personal lubricant during in-home use for subjects who perceive themselves as having sensitive skin.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single-center, medically supervised, single-arm study to evaluate the safety of an all over 2-in-1 sensual touch lotion and personal lubricant product in home-use conditions via clinical assessment.
The study will consist of two visits.
Subjects who meet the entrance criteria will receive investigational product (IP) and four subjective questionnaires for at-home completion.
The subjects will be required to use the IP at least two times on each application site, as instructed over the 1-week home-use period.
At the end of the study (Visit 2) subjects will return to the study site, at which time all unused IP and questionnaires will be returned and a final clinical assessment will be performed.
Study Type
Interventional
Enrollment (Actual)
124
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80915
- Thomas J Stephens & Associates, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Normal, healthy adults in a stable, monogamous, ongoing heterosexual relationship with current partner for at least 6 months
- Subjects comfortable discussing sensitive topics such as personal hygiene, menstruation and sexuality
- At least one partner in the couple has sensitive skin per protocol-defined criteria
- Able to read and understand English
- Voluntarily signs an Informed Consent document after the trial has been explained
- Willing to follow all study procedures, including birth control requirements
Exclusion Criteria:
- Any medical or mental health history or condition, or use of any product, drug or medication that per protocol (or in the opinion of the Investigator) might compromise the participant's safety or the analysis of results
- Participation as a research subject within timelines dictated by protocol
- Participants with relationships or employment outside protocol-defined parameters
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Formula PD-F-7716
Apply a dime-size amount on each application site as instructed during the 1-week study period
|
Apply a dime-size amount on each application site as instructed during the 1-week study period
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Physical Irritation Scores
Time Frame: One week
|
Severity of physical irritation scored by the Investigator on a scale from 0 (no irritation) to 6 (presence of lesions).
Since a score of 0 is required at baseline for inclusion in the study, this any score represents a change from baseline and the trial is considered baseline-controlled.
The number of participants with physical irritation scores after one week was recorded (along with categorical severity).
|
One week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants Reporting Subjective Irritation - Genital Application 1
Time Frame: One week
|
Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating.
The sensations included itching, burning, stinging, tingling, warming, and cooling.
The number of participants with subjective irritation scores after one week was recorded.
|
One week
|
Number of Participants Reporting Subjective Irritation - Genital Application 2
Time Frame: One week
|
Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating.
The sensations included itching, burning, stinging, tingling, warming, and cooling.
The number of participants with subjective irritation scores after one week was recorded.
|
One week
|
Number of Participants Reporting Subjective Irritation - Neck Application 1
Time Frame: One week
|
Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating.
The sensations included itching, burning, stinging, tingling, warming, and cooling.
The number of participants with subjective irritation scores after one week was recorded.
|
One week
|
Number of Participants Reporting Subjective Irritation - Neck Application 2
Time Frame: One week
|
Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating.
The sensations included itching, burning, stinging, tingling, warming, and cooling.
The number of participants with subjective irritation scores after one week was recorded.
|
One week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Sherryl Frisch, Johnson & Johnson Consumer and Personal Products Worldwide
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (Actual)
January 1, 2011
Study Completion (Actual)
January 1, 2011
Study Registration Dates
First Submitted
January 4, 2011
First Submitted That Met QC Criteria
January 5, 2011
First Posted (Estimate)
January 6, 2011
Study Record Updates
Last Update Posted (Estimate)
March 4, 2014
Last Update Submitted That Met QC Criteria
January 30, 2014
Last Verified
September 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KOYNAP0010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inadequate Lubrication
-
AllerganCompletedContact Lens LubricationUnited States
-
Indiana UniversityTerminatedSleep Hygiene, InadequateUnited States
-
Rhode Island HospitalUniversity of Puerto RicoCompletedSleep | Sleep Hygiene, InadequateUnited States, Puerto Rico
-
Boston Children's HospitalWithdrawnInadequate; Pulmonary Function, Newborn
-
Rambam Health Care CampusUnknownInadequate Preparation for Colonoscopy; Personalized Colonoscopy PreparationIsrael
-
Loma Linda UniversityAmerican Regent, Inc.CompletedInadequate Bone Height in Maxillary Posterior AreaUnited States
-
Maria Sklodowska-Curie National Research Institute...CompletedSplit-dose Bowel Preparation | Polyethylene Glycol Solution | Risk Factors Inadequate PreparationPoland
-
RTI InternationalUniversity of Rwanda; The International Livestock Research Institute (ILRI); ...Completed
-
CES UniversityIPS Fundación SIAMUnknownHIV | AIDS | Immunological Deficiency | Inadequate Immune Recovery | Viral ReplicationColombia
-
Far Eastern Memorial HospitalNational Science ConcilCompletedKnee Osteoarthritis | HA Injection | One Injection Per Week for Five Week | Synovial Fluid Composition | Synovial Fluid LubricationTaiwan
Clinical Trials on Formula PD-F-7716
-
International Centre for Diarrhoeal Disease Research...London School of Hygiene and Tropical MedicineCompletedSeverely Malnourished Infants Who Are Less Than 6 Months OldBangladesh
-
Johnson & Johnson Healthcare Products Division...Completed
-
Johnson & Johnson Consumer and Personal Products...Completed
-
Abbott NutritionCompleted
-
University Hospital, GhentWithdrawnHydration of ScarsBelgium
-
CellSight Technologies, Inc.Stanford UniversityCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
University Hospital, GhentBelgian Foundation for Burn Injuries, BelgiumCompleted
-
Ain Shams UniversityCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic LeukemiaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedExtensive Stage Small Cell Lung CancerUnited States